Dunn Marian E
Center for Human Sexuality, Department of Psychiatry, State University of New York Downstate Medical Center, 450 Clarkson Ave, Brooklyn, NY 11203-2098, USA.
J Am Osteopath Assoc. 2004 Mar;104(3 Suppl 4):S6-10.
The new modes of pharmacologic therapy give health care practitioners an unprecedented opportunity to treat patients with erectile dysfunction (ED), an undiagnosed and underreported condition. Yet even with a portfolio of effective treatment modalities, such as phosphodiesterase type 5 (PDE5) inhibitors, nonpharmacologic interventions should be considered as means to support and augment the effects of these agents. Of equal value--and necessity--is the involvement of the man's partner in both the assessment and treatment processes. Because men see the primary care physician's office as a natural and expected place in which to address issues of sexual health, those healthcare professionals who are prepared to initiate discussion of ED can offer patients and their partners the possibility of effective and enduring treatment success and the restoration of a satisfying relationship.
新的药物治疗模式为医疗从业者提供了前所未有的机会,来治疗患有勃起功能障碍(ED)的患者,这是一种未被诊断且报告不足的病症。然而,即便有一系列有效的治疗方式,如5型磷酸二酯酶(PDE5)抑制剂,非药物干预也应被视为支持和增强这些药物疗效的手段。同样重要且必要的是,男性伴侣要参与到评估和治疗过程中。由于男性将初级保健医生办公室视为解决性健康问题的自然且预期的场所,那些准备好开启勃起功能障碍讨论的医疗专业人员,能够为患者及其伴侣提供有效且持久治疗成功以及恢复满意关系的可能性。